MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 202 filers reported holding MYRIAD GENETICS INC in Q2 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $166,126 | -30.8% | 10,357 | 0.0% | 0.04% | -30.2% |
Q2 2023 | $240,075 | -0.2% | 10,357 | 0.0% | 0.06% | -4.5% |
Q1 2023 | $240,593 | +60.1% | 10,357 | 0.0% | 0.07% | +53.5% |
Q4 2022 | $150,280 | -24.1% | 10,357 | 0.0% | 0.04% | -29.5% |
Q3 2022 | $198,000 | +5.3% | 10,357 | 0.0% | 0.06% | -3.2% |
Q2 2022 | $188,000 | -28.0% | 10,357 | 0.0% | 0.06% | -19.2% |
Q1 2022 | $261,000 | -8.7% | 10,357 | 0.0% | 0.08% | -8.2% |
Q4 2021 | $286,000 | -14.4% | 10,357 | 0.0% | 0.08% | -18.3% |
Q3 2021 | $334,000 | +5.4% | 10,357 | 0.0% | 0.10% | +4.0% |
Q2 2021 | $317,000 | +0.6% | 10,357 | 0.0% | 0.10% | -5.7% |
Q1 2021 | $315,000 | -5.4% | 10,357 | -38.6% | 0.11% | -11.7% |
Q4 2020 | $333,000 | +51.4% | 16,857 | 0.0% | 0.12% | +41.2% |
Q3 2020 | $220,000 | +15.2% | 16,857 | 0.0% | 0.08% | +6.2% |
Q2 2020 | $191,000 | -20.7% | 16,857 | 0.0% | 0.08% | -29.8% |
Q1 2020 | $241,000 | -25.4% | 16,857 | +42.2% | 0.11% | -16.8% |
Q4 2019 | $323,000 | – | 11,857 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 6,635,000 | $106,425 | 3.51% |
Glenview Capital Management | 3,783,982 | $60,695,071 | 1.37% |
AMH Equity Ltd | 47,285 | $758,451 | 0.83% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,973,312 | $31,651,924 | 0.75% |
EARNEST PARTNERS LLC | 3,473,281 | $55,711,427 | 0.32% |
AIMZ Investment Advisors, LLC | 40,985 | $657,399 | 0.29% |
PEREGRINE CAPITAL MANAGEMENT LLC | 280,767 | $4,503,503 | 0.13% |
Beverly Hills Private Wealth, LLC | 19,687 | $315,779 | 0.09% |
Artisan Partners Limited Partnership | 2,537,147 | $40,695,838 | 0.07% |
Jump Financial, LLC | 84,924 | $1,362,181 | 0.05% |